Fiera Apex emphasizes the importance of identifying high-quality small and mid-cap companies with strong management teams and sustainable competitive advantages for investors, particularly in the healthcare and technology sectors. The asset manager’s report highlights the healthcare sector’s long-term growth potential driven by innovation, resilient demand, and solid fundamentals. In particular, opportunities within the biotechnology subsector are promising, with companies focusing on addressing unmet medical needs and tapping into the growing prescription drug market.
On the technology front, small and mid-cap firms focusing on cloud computing, artificial intelligence, and digital transformation are also worth considering. There are significant opportunities within AI for companies that can effectively handle complex data processing needs. As cloud computing becomes the dominant form of computing, companies that can innovate and provide modern functionality will have a competitive edge.
The report also points out that there is significant waste in the healthcare sector, with approximately a quarter of healthcare spending considered unnecessary. Issues such as inadequate diagnostics and administrative complexity contribute to this waste. In the tech sector, companies that can replace legacy point solutions with innovative platforms have the potential to tap into vast market opportunities, especially in industries like construction and public administration.
Overall, Fiera Apex’s research underscores the importance of targeting companies with strong growth potential, robust fundamentals, and innovative solutions in both the healthcare and technology sectors for long-term investment success.
Source
Photo credit www.fundssociety.com